Stocks and Investing Stocks and Investing
Fri, October 28, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Hedberg Maintained (BSY) at Buy with Decreased Target to $44 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tito Labarta Downgraded (BSBR) to Strong Sell and Decreased Target to $5 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Adam Jonas Maintained (BWA) at Sell with Increased Target to $35 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Daniel Tamayo Maintained (BUSE) at Buy with Increased Target to $29 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Gesuale Maintained (CACI) at Buy with Increased Target to $324 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tobey Sommer Maintained (CACI) at Strong Buy with Increased Target to $345 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jiong Shao Maintained (BZ) at Hold with Decreased Target to $15 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Joshua Pokrzywinski Maintained (CARR) at Buy with Increased Target to $45 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Nicole Deblase Downgraded (CAT) to Hold and Increased Target to $221 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jamie Cook Maintained (CAT) at Buy with Increased Target to $255 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Seth Weber Maintained (CAT) at Hold with Increased Target to $218 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Courtney Yakavonis Maintained (CAT) at Sell with Increased Target to $174 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Mishan Maintained (BAX) at Buy with Decreased Target to $73 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Larry Biegelsen Maintained (BAX) at Hold with Decreased Target to $59 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jayson Bedford Maintained (BAX) at Buy with Decreased Target to $61 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jiong Shao Maintained (BABA) at Buy with Decreased Target to $114 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Elyse Greenspan Maintained (AXS) at Hold with Increased Target to $55 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Charles Shi Maintained (AXTI) at Strong Buy with Decreased Target to $6 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Laurent Favre Downgraded (AXTA) to Hold and Held Target at $27 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Vincent Andrews Maintained (AXTA) at Hold with Decreased Target to $28 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jamie Cook Maintained (ALSN) at Hold with Increased Target to $49 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Courtney Yakavonis Maintained (ALSN) at Sell with Increased Target to $33 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Walsh Maintained (ALLE) at Hold with Increased Target to $116 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Joshua Pokrzywinski Maintained (ALLE) at Hold with Increased Target to $107 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Salveen Richter Maintained (ALNY) at Strong Buy with Increased Target to $270 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (ALNY) at Hold with Decreased Target to $210 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gena Wang Maintained (ALNY) at Buy with Decreased Target to $236 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Wilde Downgraded (AMBP) to Hold and Decreased Target to $5 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gabe Hajde Maintained (AMBP) at Hold with Decreased Target to $3.75 on, Oct 28th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $145 on, Oct 28th, 2022

Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $145 on, Oct 28th, 2022


Published on 2024-10-27 23:43:27 - WOPRAI, Michael Wiederhorn
  Print publication without navigation


Michael Wiederhorn of Oppenheimer, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $175 to $145 on, Oct 28th, 2022.

Michael has made no other calls on AMED in the last 4 months.



There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022
  • Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022


These are the ratings of the 3 analyists that currently disagree with Michael

  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
  • Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022

Contributing Sources